Search by Drug Name or NDC

NDC 00591-2312-15 Alvimopan 12 mg/1 Details

Alvimopan 12 mg/1

Alvimopan is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is ALVIMOPAN.

MedlinePlus Drug Summary

Alvimopan is used to help the bowel recover more quickly after bowel surgery, so that you can eat solid foods and have regular bowel movements. Alvimopan is in a class of medications called peripherally acting mu-opioid receptor antagonists. It works by protecting the bowel from the constipation effects of opioid (narcotic) medications that are used to treat pain after surgery.

Related Packages: 00591-2312-15
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Alvimopan

Product Information

NDC	00591-2312
Product ID	0591-2312_5b5b2646-f328-4a7f-b83c-cae8e2720404
Associated GPIs	52580010000120
GCN Sequence Number	064325
GCN Sequence Number Description	alvimopan CAPSULE 12 MG ORAL
HIC3	H3Y
HIC3 Description	MU-OPIOID RECEPTOR ANTAGONISTS,PERIPHERALLY-ACTING
GCN	13285
HICL Sequence Number	035795
HICL Sequence Number Description	ALVIMOPAN
Brand/Generic	Generic
Proprietary Name	Alvimopan
Proprietary Name Suffix	n/a
Non-Proprietary Name	Alvimopan
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	12
Active Ingredient Units	mg/1
Substance Name	ALVIMOPAN
Labeler Name	Actavis Pharma, Inc.
Pharmaceutical Class	Opioid Antagonist [EPC], Opioid Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA208295
Listing Certified Through	2024-12-31

Package

NDC 00591-2312-15 (00591231215)

Pricing Information	N/A
NDC Package Code	0591-2312-15
Billing NDC	00591231215
Package	30 BLISTER PACK in 1 CARTON (0591-2312-15) / 1 CAPSULE in 1 BLISTER PACK (0591-2312-45)
Marketing Start Date	2020-12-01
NDC Exclude Flag	N